Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Portlock

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Current Oncology Reports|December 21, 2000
New developments in lymphoma clinical trialsC S Portlock
Cancer Treatment Reports|March 1, 1982
Deferral of initial therapy for advanced indolent lymphomasC S Portlock
International Journal of Clinical & Laboratory Research|January 1, 1992
Management of non-Hodgkin's lymphomaC S Portlock
Seminars in Oncology|September 1, 1980
Management of the indolent non-Hodgkin's lymphomasC S Portlock
Seminars in Oncology|February 1, 1990
Management of the low-grade non-Hodgkin's lymphomasC S Portlock
The Cancer Journal From Scientific American|October 20, 1999
Greater curability in advanced Hodgkin's disease?C S Portlock
Seminars in Oncology|December 1, 1986
Therapeutic approaches to the treatment of hairy cell leukemiaC S Portlock
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Dose density and dose intensity: where does CHOP go from here?C S Portlock
The Medical Clinics of North America|May 1, 1984
Hodgkin's diseaseC S Portlock
Seminars in Hematology|January 1, 1983
"Good risk" non-Hodgkin lymphomas: approaches to managementC S Portlock
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Current Oncology Reports|December 21, 2000
New developments in lymphoma clinical trialsC S Portlock
Cancer Treatment Reports|March 1, 1982
Deferral of initial therapy for advanced indolent lymphomasC S Portlock
International Journal of Clinical & Laboratory Research|January 1, 1992
Management of non-Hodgkin's lymphomaC S Portlock
Seminars in Oncology|September 1, 1980
Management of the indolent non-Hodgkin's lymphomasC S Portlock
Seminars in Oncology|February 1, 1990
Management of the low-grade non-Hodgkin's lymphomasC S Portlock
The Cancer Journal From Scientific American|October 20, 1999
Greater curability in advanced Hodgkin's disease?C S Portlock
Seminars in Oncology|December 1, 1986
Therapeutic approaches to the treatment of hairy cell leukemiaC S Portlock
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Dose density and dose intensity: where does CHOP go from here?C S Portlock
The Medical Clinics of North America|May 1, 1984
Hodgkin's diseaseC S Portlock
Seminars in Hematology|January 1, 1983
"Good risk" non-Hodgkin lymphomas: approaches to managementC S Portlock
Pageof 6